Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jason Bacharach, Iqbal Ike K Ahmed, Elizabeth D Sharpe, Michael S Korenfeld, Steven Zhang & Christophe Baudouin. (2023) Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial. Clinical Ophthalmology 17, pages 2575-2588.
Read now
Read now
Carl Erb, Ingeborg Stalmans, Milko Iliev & Francisco José Muñoz-Negrete. (2021) Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost. Clinical Ophthalmology 15, pages 931-938.
Read now
Read now
Jack Phu, Ashish Agar, Henrietta Wang, Katherine Masselos & Michael Kalloniatis. (2021) Management of open‐angle glaucoma by primary eye‐care practitioners: toward a personalised medicine approach. Clinical and Experimental Optometry 104:3, pages 367-384.
Read now
Read now
Anastasios G. Konstas, Antoine Labbé, Andreas Katsanos, Frances Meier-Gibbons, Murat Irkec, Konstadinos G. Boboridis, Gábor Holló, Julián García-Feijoo, Gordon N. Dutton & Christophe Baudouin. (2021) The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability. Expert Opinion on Drug Safety 20:4, pages 453-466.
Read now
Read now
Ingeborg Stalmans, Hans Lemij, Jonathan Clarke & Christophe Baudouin. (2020) Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments. Clinical Ophthalmology 14, pages 3675-3680.
Read now
Read now
Mario A Economou, Helene Kolstad Laukeland, Iwona Grabska-Liberek & Jean-François Rouland. (2018) Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study. Clinical Ophthalmology 12, pages 2399-2407.
Read now
Read now
Victoria M Addis & Eydie Miller-Ellis. (2018) Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy. Clinical Ophthalmology 12, pages 2649-2657.
Read now
Read now
Articles from other publishers (28)
Luis Fernando Valladales-Restrepo, María Camila Oyuela-Gutiérrez, Ana Camila Delgado-Araujo & Jorge Enrique Machado-Alba. (2023) Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study. Pharmaceuticals 16:5, pages 743.
Crossref
Crossref
Pilar Pérez-García, Bárbara Burgos-Blasco, Laura Morales-Fernández, Ana Fernández-Ruiz-Morón, Verónica Gómez-Calleja, Carlos Oribio-Quinto, Isabel Collado-Vincueria, Julian Garcia-Feijoo & Jose María Martinez-de-la-Casa. (2023) Prescription trends for preservative free glaucoma medication in a public health system. European Journal of Ophthalmology, pages 112067212311700.
Crossref
Crossref
Sihem Lazreg, Rachid Garout, Fouzia Boulanab, Djalil Aberkane, Mustapha Djabour, Hakim Boudedja, Asma Acheli, Amine Derdour, Nairouz Zine El Abidine & Nadia Ghemri. (2023) Atteinte de la surface oculaire chez les patients glaucomateux : avis d’experts et algorithme de prise en charge en Algérie. Journal Français d'Ophtalmologie 46:2, pages 152-162.
Crossref
Crossref
Nupur Vasdev, Nakshatra Chaudhari, Suryanarayana Polaka, Kuldeep Rajpoot, Piyush Gondaliya, Adil Ali Sayyed, Pinaki Sengupta & Rakesh Kumar Tekade. (2023) Current progress in preservative-free topical ophthalmic formulations. Journal of Drug Delivery Science and Technology 79, pages 103996.
Crossref
Crossref
Katarzyna Asendrych-Wicik, Jakub Zarczuk, Katarzyna Walaszek, Tomasz Ciach & Magdalena Markowicz-Piasecka. (2023) Trends in development and quality assessment of pharmaceutical formulations - F2α analogues in the glaucoma treatment. European Journal of Pharmaceutical Sciences 180, pages 106315.
Crossref
Crossref
S. Yu. Petrov, O. M. Kalinina, A. N. Zhuravleva, O. M. Filippova, L. V. Yakubova, L. V. Vasilenkova, S. M. Kosakyan & O. I. Markelova. (2022) Effectiveness and safety of hypotensive therapy of primary glaucoma with a Russian generic fixed combination of dorzolamide and timolol. Russian Ophthalmological Journal 15:3, pages 52-60.
Crossref
Crossref
Luca D'andrea, Marina Montemagni, Giuseppe Celenza, Roberto Iorio & Ciro Costagliola. (2022) Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?. British Journal of Clinical Pharmacology 88:9, pages 3947-3949.
Crossref
Crossref
Anna-Sophie Thein, Anne Hedengran, Augusto Azuara-Blanco, Reiko Arita, Barbara Cvenkel, Gus Gazzard, Steffen Heegaard, Cintia S. de Paiva, Goran Petrovski, Verena Prokosch-Willing, Tor P. Utheim, Gianni Virgili & Miriam Kolko. (2022) Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus Statement. American Journal of Ophthalmology 241, pages 190-197.
Crossref
Crossref
Chak Hin Tam, Matthew S. Alexander & Sheng Qi. (2022) Precision coating of ocular devices/contact lenses by nanoelectrospray additive printing. Materials & Design 219, pages 110782.
Crossref
Crossref
Anne Guldhammer Skov, Amalie Santaolalla Rives, Josefine Freiberg, Gianni Virgili, Augusto Azuara‐Blanco & Miriam Kolko. (2021) Comparative efficacy and safety of preserved versus preservative‐free beta‐blockers in patients with glaucoma or ocular hypertension: a systematic review. Acta Ophthalmologica 100:3, pages 253-261.
Crossref
Crossref
Sophie Lemmens, Luca Rossetti, Francesco Oddone, Gordana Sunaric-Mégevand, Anton Hommer, Evelien Vandewalle, Maria Francesca Cordeiro, Andrew McNaught, Giovanni Montesano & Ingeborg Stalmans. (2021) Comparison of preserved bimatoprost 0.01% with preservative-free tafluprost: A randomised, investigator-masked, 3-month crossover, multicentre trial, SPORT II. European Journal of Ophthalmology 32:2, pages 968-975.
Crossref
Crossref
Gabriel Alviset, Yohann Corvis, Karim Hammad, Josiane Lemut, Marc Maury, Nathalie Mignet & Vincent Boudy. (2022) New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma. Pharmaceutics 14:2, pages 453.
Crossref
Crossref
Olivia Müllertz, Anne Hedengran, Zaynab Ahmad Mouhammad, Josefine Freiberg, Richárd Nagymihály, Jette Jacobsen, Susan Weng Larsen, Jeffrey Bair, Tor P Utheim, Darlene A Dartt, Steffen Heegaard, Goran Petrovski & Miriam Kolko. (2021) Impact of benzalkonium chloride-preserved and preservative-free latanoprost eye drops on cultured human conjunctival goblet cells upon acute exposure and differences in physicochemical properties of the eye drops. BMJ Open Ophthalmology 6:1, pages e000892.
Crossref
Crossref
Núria Comes, Xavier Gasull & Gerard Callejo. (2021) Proton Sensing on the Ocular Surface: Implications in Eye Pain. Frontiers in Pharmacology 12.
Crossref
Crossref
Bo Kyung Kim, Si Nae Kim & Joon Mo Kim. (2021) The Efficacy and Safety of Preservative-containing and Preservative-free Brimonidine-Timolol Fixed Combination in Normal Tension Glaucoma. Journal of the Korean Ophthalmological Society 62:10, pages 1407-1414.
Crossref
Crossref
T. N. Malishevskaya, S. Yu. Petrov, S. M. Kosakyan & S. A. Vlasova. (2021) When is preservative-free therapy of glaucoma needed and advisable?. Russian Ophthalmological Journal 14:3, pages 25-31.
Crossref
Crossref
Line Storgaard, Thuy Linh Tran, Josefine Clement Freiberg, Alexander S. Hauser & Miriam Kolko. (2021) Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development. Frontiers in Medicine 8.
Crossref
Crossref
Eugene B. McLaurin, David Evans, Carolyn S. Repke, Michelle A. Sato, Paul J. Gomes, Erin Reilly, Nysha Blender, Fabiana Q. Silva, Srilatha Vantipalli, Jamie L. Metzinger, Andrea Gibson & Michael H. Goldstein. (2021) Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis. American Journal of Ophthalmology 229, pages 288-300.
Crossref
Crossref
Paul Harasymowycz, Cindy Hutnik, Jean-François Rouland, Francisco J. Muñoz Negrete, Mario A. Economou, Philippe Denis & Christophe Baudouin. (2021) Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis. Advances in Therapy 38:6, pages 3019-3031.
Crossref
Crossref
Chau-Minh Phan, Han Qiao, Alan Yee & Lyndon Jones. (2021) Deposition of Fluorescently Tagged Lysozyme on Contact Lenses in a Physiological Blink Model. Eye & Contact Lens: Science & Clinical Practice 47:2, pages 127-133.
Crossref
Crossref
N. I. Kurysheva. (2020) Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part I. Ophthalmology in Russia 17:3s, pages 542-549.
Crossref
Crossref
Tianyang ZhouYan MiaoZhengyan LiPing LuZhen LiangJingjing YangJijun HeHuiyun XiaZhen ZhangJunjie Zhang. (2020) A Comparative Ocular Pharmacokinetics Study of Preservative-Free Latanoprost Unit-Dose Eye Drops and a Benzalkonium Chloride-Preserved Branded Product Following Topical Application to Rabbits. Journal of Ocular Pharmacology and Therapeutics 36:7, pages 522-528.
Crossref
Crossref
N. V. Makashova, A. E. Vasilyeva & O. Yu. Kolosova. (2020) Ocular Surface Status in Newly Diagnosed Glaucoma Cases. Ophthalmology in Russia 17:1, pages 105-110.
Crossref
Crossref
E.V. Karlova, S.Yu. Petrov & V.N. Germanova. (2020) Preservative-free fixed combination in the treatment of open-angle glaucoma and ocular hypertension: the VISIONARY Study (EUPAS22204). Vestnik oftal'mologii 136:4, pages 76.
Crossref
Crossref
Konstantin Tachkov, Anton Vassilev & Stanislava Kostova. (2019) Modeling the Pharmacotherapy Cost and Outcomes of Primary Open-Angle Glaucoma With Dry Eye. Frontiers in Public Health 7.
Crossref
Crossref
Frances Meier-Gibbons, Michael S. Berlin & Marc Töteberg-Harms. (2019) Influence of new treatment modalities on adherence in glaucoma. Current Opinion in Ophthalmology 30:2, pages 104-109.
Crossref
Crossref
V. V. Neroev, A. V. Zolotarev, E. V. Karlova, O. A. Kiseleva, M. M. Shishkin & V. N. Germanova. (2019) Influence of treatment adherence on the progression of primary open-angle glaucoma in clinical setting. Vestnik oftal'mologii 135:6, pages 42.
Crossref
Crossref
Chak Hin Tam, Matthew Alexander & Sheng Qi. (2022) Precision Coating of Ocular Devices/Contact Lenses by Nano-Electrospray Additive Printing. SSRN Electronic Journal.
Crossref
Crossref